Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 375

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 375
---
5 Offering (See Note 8), the Company sold (i) 15,000shares of Common Stock, (ii) Pre-Funded Warrants to purchase up to 112,551shares of Common Stock, and (iii) Common Warrants to purchase up to 127,551shares of common stock, at a combined public offering price of $ 39.20per share and Warrant. During the three months ended March 31, 2025, 91,214shares of its common stock were issued following the exercise of certain Pre-Funded Warrants. During the three months ended June 30, 2025, 10,550shares of its common stock were issued following the exercise of certain Pre-Funded Warrants. At September 30, 2025, the remaining 10,787Pre-Funded Warrants remain exercisable. The Pre-Funded Warrants are exercisable at any time and have no expiration date Additionally, in connection with the February 2025 Offering, the Company issued the February 2025 Common Warrants to purchase up to 127,551shares of common stock with an exercise price of $ 39.20per share, which are immediately exercisable upon stockholder approval and have a term of exercise equal to five yearsfollowing date of the initial exercise date. The exercise price and number of shares of Common Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar events affecting the Common Stock and the exercise price. F-27

A summary of outstanding
warrants as of September 30, 2025 is as follows:

|                                         |     | Number of 
 Warrants  |         |     | Weighted 
 Average  
 Exercise 
 Price    |           |     | Weighted         
 Average          
 Remaining        
 Contractual Life 
 (in years)       |                    |
|:----------------------------------------|:----|:----------|--------:|:----|:---------|----------:|:----|:-----------------|-------------------:|
| Public and Private Placement Warrants   |     |           |   4,596 |     | $        | 23,000.00 |     |                  |               3.38 |
| February 2024 Series A Common Warrants  |     |           |     306 |     |          |  2,780.00 |     |                  |               1.87 |
| September 2024 Series C Common Warrants |